Roche Holding AG (ETR:RHO)

Germany flag Germany · Delayed Price · Currency is EUR
285.80
-7.60 (-2.59%)
At close: Aug 1, 2025
-2.59%
Market Cap237.99B
Revenue (ttm)67.98B
Net Income (ttm)10.10B
Shares Outn/a
EPS (ttm)12.57
PE Ratio23.57
Forward PE13.68
Dividend9.70 (3.39%)
Ex-Dividend DateMar 27, 2025
Volume412
Average Volume194
Open290.60
Previous Close293.40
Day's Range282.80 - 290.60
52-Week Range282.00 - 314.00
Betan/a
RSI38.62
Earnings DateJul 24, 2025

About Exscientia

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagn... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1896
Employees 103,249
Stock Exchange Deutsche Börse Xetra
Ticker Symbol RHO
Full Company Profile

Financial Performance

In 2024, Roche Holding AG's revenue was 62.40 billion, an increase of 3.23% compared to the previous year's 60.44 billion. Earnings were 8.28 billion, a decrease of -28.01%.

Financial numbers in EUR Financial Statements

News

There is no news available yet.